SAALI Biotechnologies Aps: Financial statements 2023
CVR: 38619292
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
SAALI Biotechnologies Aps (CVR 38619292) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK -1,109 compared with DKK -1,896 the year before. Equity in the 2023 report amounted to DKK -11,866.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -1,109
- Equity
- DKK -11,866
- Total Assets
- DKK 0
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 0 | 0 | -1K | -12K | 0 |
| 2022 | - | - | -2K | -11K | 0 |
| 2021 | 0 | 0 | -44K | -10K | 0 |
| 2020 | 0 | 0 | 0 | -10K | 0 |
| 2019 | - | -4K | -44K | -10K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
SAALI Biotechnologies Aps has published its annual report for 2022. The net result was DKK -1,896.
About SAALI Biotechnologies Aps
SAALI Biotechnologies Aps is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 2017. The company is registered under the industry Anden forarbejdning og konservering af frugt og grøntsager. The management consists of Sander Sieuwerts and Lina Nadirova. The company is owned by Sander Sieuwerts and Lina Nadirova. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -1,348 compared with DKK -1,237 the year before. Equity in the 2025 report amounted to DKK -13,201.